E-Mindfulness Approaches for Living After Breast Cancer

Short Title: NRG-CC015

Enrollment Status: Recruiting

NCT #: NCT06748222

Specialty Area: Oncology

Condition Studied: Breast Cancer Survivorship with Elevated Depressive Symptoms

Age Groups: Adult; Older Adult

Phase: III

Study Information

Summary / Purpose

To find out which digital mindfulness approach—live online or app-based—is more effective at reducing depressive symptoms in younger breast cancer survivors.

Study Type: Interventional

Accepts Healthy Volunteers: No

Who Can Participate

Eligibility Criteria:

Adults 18+ years of age
Diagnosed with breast cancer at or before age 50
Completed primary cancer treatment (surgery, radiation, and/or chemotherapy) at least 6 months ago
Elevated depressive symptoms

What's Involved

Participation in the study will include:

Enrollment in one of three mindfulness-based programs:

1. A live, instructor-led version delivered over Zoom

2. A self-paced, app-based version

3. A meditation-only group

Questionnaires

Principal Investigator

Lee Schwartzberg, MD

Oncology

A Member of

(775) 982–5000

Renown Hematology/Oncology

View Provider

Additional Information

Location: Renown Health, Office of Clinical Research
Address:

1500 E 2nd St. Reno, NV 89502

General Research: 775-982-3646
Oncology Research: 775-982-5050
Email: Renown-CRD@renown.org

Complete Study Details: https://clinicaltrials.gov/study/NCT06748222

Disclaimer: This listing gives you general information about the study and isn't part of the official consent process. If you decide to learn more, the research team will talk with you and check if you meet any additional requirements to join the study.

Health & Wellness eNews